This is interesting given the enrichment of adaptive immunity pathways in genes differentially expressed between control and FSHD PBMCs, particularly considering a report connecting DUX4 expression in tumours to suppression of both MHC-I and MHC-II related gene expression [105, 106]. The gene discussed is DUX4; the disease is neoplasm.